| Year |
Citation |
Score |
| 2019 |
Foley AR, Finn TS, Kung T, Hatami A, Lee HW, Jia M, Rolandi M, Raskatov JA. Trapping and Characterization of Non-Toxic Aβ42 Aggregation Intermediates. Acs Chemical Neuroscience. PMID 31319029 DOI: 10.1021/Acschemneuro.9B00340 |
0.456 |
|
| 2019 |
Bilousova T, Melnik M, Miyoshi E, Gonzalez BL, Poon WW, Vinters HV, Miller CA, Corrada MM, Kawas C, Hatami A, Albay R, Glabe C, Gylys KH. Apolipoprotein E/Aβ Complex Accumulates in AD Cortical Synapses via apoE Receptors and Is Enhanced by APOE4. The American Journal of Pathology. PMID 31108099 DOI: 10.1016/J.Ajpath.2019.04.010 |
0.621 |
|
| 2019 |
Bilousova T, Elias CJ, Melnik M, Miyoshi E, Campagna JJ, Simmons B, Hatami A, Zhu C, Jun M, Cohn W, Jagodzinska B, Vadivel K, Spilman P, Garg N, Gylys KH, et al. P4-057: PURIFICATION AND CHARACTERIZATION OF SUBPOPULATIONS OF EXTRACELLULAR VESICLES FROM AD AND PD BRAIN AND THEIR SUPPRESSION BY NSMASE2 INHIBITORS Alzheimer's & Dementia. 15: P1294-P1295. DOI: 10.1016/J.Jalz.2019.06.3717 |
0.329 |
|
| 2018 |
Campagna J, Spilman P, Jagodzinska B, Bai D, Hatami A, Zhu C, Bilousova T, Jun M, Elias CJ, Pham J, Cole G, LaDu MJ, Jung ME, Bredesen DE, John V. A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer's disease mouse model. Scientific Reports. 8: 17574. PMID 30514854 DOI: 10.1038/S41598-018-35687-8 |
0.42 |
|
| 2017 |
Hatami A, Monjazeb S, Milton S, Glabe CG. Familial Alzheimer's disease mutations within the amyloid precursor protein alter the aggregation and conformation of the amyloid beta peptide. The Journal of Biological Chemistry. PMID 28049728 DOI: 10.1074/Jbc.M116.755264 |
0.665 |
|
| 2016 |
Knight EM, Kim SH, Kottwitz JC, Hatami A, Albay R, Suzuki A, Lublin A, Alberini CM, Klein WL, Szabo P, Relkin NR, Ehrlich M, Glabe CG, Gandy S, Steele JW. Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes. Neurology® Neuroimmunology & Neuroinflammation. 3: e237. PMID 27218118 DOI: 10.1212/Nxi.0000000000000237 |
0.675 |
|
| 2015 |
Hatami A, Monjazeb S, Glabe C. The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils. Journal of Alzheimer's Disease : Jad. PMID 26682688 DOI: 10.3233/Jad-150696 |
0.624 |
|
| 2015 |
Tan Z, Dai W, van Erp TG, Overman J, Demuro A, Digman MA, Hatami A, Albay R, Sontag EM, Potkin KT, Ling S, Macciardi F, Bunney WE, Long JD, Paulsen JS, et al. Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin. Molecular Psychiatry. PMID 26100538 DOI: 10.1038/Mp.2015.81 |
0.545 |
|
| 2015 |
Hatami A, Chesselet MF. Transgenic rodent models to study alpha-synuclein pathogenesis, with a focus on cognitive deficits. Current Topics in Behavioral Neurosciences. 22: 303-30. PMID 25218491 DOI: 10.1007/7854_2014_355 |
0.343 |
|
| 2014 |
Hatami A, Albay R, Monjazeb S, Milton S, Glabe C. Monoclonal antibodies against Aβ42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain. The Journal of Biological Chemistry. 289: 32131-43. PMID 25281743 DOI: 10.1074/Jbc.M114.594846 |
0.649 |
|
| 2014 |
Pensalfini A, Albay R, Rasool S, Wu JW, Hatami A, Arai H, Margol L, Milton S, Poon WW, Corrada MM, Kawas CH, Glabe CG. Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques. Neurobiology of Disease. 71: 53-61. PMID 25092575 DOI: 10.1016/J.Nbd.2014.07.011 |
0.643 |
|
| 2012 |
Nussbaum JM, Schilling S, Cynis H, Silva A, Swanson E, Wangsanut T, Tayler K, Wiltgen B, Hatami A, Rönicke R, Reymann K, Hutter-Paier B, Alexandru A, Jagla W, Graubner S, et al. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β. Nature. 485: 651-5. PMID 22660329 DOI: 10.1038/Nature11060 |
0.674 |
|
| 2006 |
Spilman P, Campagna J, Jagodzinska B, Zhu C, Bai D, Hatami A, Bilousova T, Jun M, Alam MP, Elias CJ, Soler J, Bredesen DE, John V. O5-06-06: NORMALIZATION OF HIPPOCAMPAL SIRTUIN 1 LEVELS IN A MURINE APOLIPOPROTEIN E4-5XFAD MODEL OF AD RESTORES COGNITIVE FUNCTION Alzheimer's & Dementia. 14: P1659-P1660. DOI: 10.1016/J.Jalz.2018.06.3030 |
0.332 |
|
| Show low-probability matches. |